Navigation Links
Allegro Diagnostics Closes $4 Million Round to Develop and Commercialize Lung Cancer Molecular Diagnostics Based on Gene Expression
Date:3/7/2008

Jerome Brody, MD Joins Company as Chief Scientific Officer

BOSTON, March 7 /PRNewswire/ -- Allegro Diagnostics, a leader in the field of molecular diagnostics for lung cancer, has announced completion of $4 million in Series A financing. Kodiak Venture Partners led the round and was joined by Catalyst Health Ventures and Boston University. Allegro Diagnostics will develop and commercialize products based on gene expression technology developed by Jerome Brody, MD and Avrum Spira, MD, MSc within the Pulmonary Center at the Boston University School of Medicine. Jerome Brody, MD, formerly head of the Pulmonary Center, has joined Allegro Diagnostics as the company's Chief Scientific Officer.

"We are truly fortunate to have a team with world class science and financial backing from outstanding venture partners," said Dan Rippy, President and CEO of Allegro Diagnostics. "The Series A financing will enable us to take our first product, based on intellectual property developed at the Boston University School of Medicine, into the clinic to provide earlier, more accurate diagnosis of suspected lung cancer for patients and their doctors. The clinical community considers earlier identification of lung cancer a major unmet need in treating the disease, so our diagnostic should provide significant benefit."

In conjunction with the financing, Andrey Zarur, General Partner with Kodiak Venture Partners, and Josh Phillips, General Partner with Catalyst Health Ventures, joined the company's board of directors. "Allegro opens a novel alternative to assist physicians in diagnosing and potentially treating lung cancer," said Andrey Zarur, who became Chairman of the company as part of this round of financing. "Kodiak is very excited to join the world-leading scientists and first-class entrepreneurial team at Allegro."

"Catalyst is pleased to participate in the exciting work Allegro is furthering in the diagnosis of lung cancer," said Josh Phillips, General Partner with Catalyst Health Ventures. "Allegro's technology is extremely promising and has the potential to bring real value to patients by providing earlier, more accurate, and less invasive diagnosis of this devastating disease."

About Lung Cancer

Lung cancer is the leading cause of cancer death in the industrialized world, responsible for more than 1.3 million deaths per year worldwide. In the U.S., lung cancer kills more people than colon, breast, prostate, and ovarian cancers combined. According to the American Cancer Society, more than 200,000 new cases of lung cancer are diagnosed each year in the U.S., and more than 160,000 deaths occur annually from the disease. While lung cancer can be cured by surgery if caught in the early stages, 65-80% of lung cancer patients present with late stage disease. The five-year survival rate for lung cancer patients is roughly 15%, a rate that has remained unchanged for several decades.

About Allegro Diagnostics

Allegro Diagnostics was founded in 2006 to develop and commercialize molecular diagnostics in lung cancer and other epithelial diseases using proprietary gene expression technology originating within the Pulmonary Center at the Boston University School of Medicine. The company will initially focus on more accurate diagnosis of early stage lung cancer. Allegro Diagnostics is privately funded by Kodiak Venture Partners, Catalyst Health Ventures, and Boston University. For more information, visit the website of Allegro Diagnostics at: http://www.allegrodx.com.

About Kodiak Venture Partners

Founded in 1999, Kodiak manages three funds totaling $676M and targets companies in North America. Kodiak focuses on seed and early stage investments in emerging communications/wireless, semiconductor/equipment, software/services, internet/new media, and life technology companies. Kodiak's partners are successful high-technology business entrepreneurs who take a hands-on approach to building market leaders. Previous Kodiak investments have included ALIS Corporation, Fluxion Biosciences, and Groove Mobile. For more information on Kodiak Venture Partners, visit: http://www.kodiakvp.com.

About Catalyst Health Ventures

Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of its strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Our disciplined investment process leverages both intellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. For more information on Catalyst Health Ventures, visit: http://www.catalysthealthventures.com.


'/>"/>
SOURCE Allegro Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Quest Diagnostics to Collaborate with Google on New Health Offering
2. Birla Sun Life Insurance Names Quest Diagnostics its Exclusive Provider of Health Assessment Services in India
3. QED International Associates Announces Changes to the HealthShares(TM) Diagnostics Index
4. Quest Diagnostics to Speak at Wachovia Securities 2008 Healthcare Conference
5. Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise
6. Dominion Diagnostics Supports Rhode Islands Toys for Tots Initiative at Its 2007 Holiday Celebration
7. Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference
8. Studies Investigate Diagnostic Performance and Reproducibility of Pathwork Diagnostics Tissue of Origin Test
9. DeviceSpace Career Fair Opens Doors for Hundreds of Medical Device and Diagnostics Career Candidates
10. QED International Associates Announces Changes to the HealthShares(TM) Composite, and the HealthShares(TM) Diagnostics Indexes
11. GSW Worldwide Named Agency of Record for BioBehavioral Diagnostics Companys MMAT/ADHD(TM) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology: